CGC
Canopy Growth Corporation
CGC lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CGC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
CGC's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CGC PE Valuation
CGC has no meaningful PE right now: it lost money over the past year.
CGC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CGC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CGC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.53 | +$1.38 |
| Q2 2026 | -$0.47 | +$2.47 |
| Q1 2026 | -$0.60 | +$3.31 |
| Q4 2025 | -$1.25 | +$2.52 |
| Q3 2025 | -$1.91 | +$2.92 |
| Q2 2025 | -$2.94 | +$3.87 |
| Q1 2025 | -$3.91 | +$2.27 |
| Q4 2024 | -$3.77 | +$6.37 |
CGC is still losing money, but far less than before: $0.53 per share over the past year, against $53.01 at its worst in late 2022.
CGC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $57.2M | +22% |
| Q2 2026 | $57.1M | +13% |
| Q1 2026 | $50.1M | +9.6% |
| Q4 2025 | $52.4M | -0.3% |
| Q3 2025 | $46.9M | +5.9% |
| Q2 2025 | $50.7M | +8.9% |
| Q1 2025 | $45.7M | -11% |
| Q4 2024 | $52.6M | -4.8% |
CGC's revenue is recovering but still below its 2020 peak: $57M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -28% | -2.9 points |
| Q2 2026 | -27% | +4.1 points |
| Q1 2026 | -134% | -106 points |
| Q4 2025 | -35% | -3.5 points |
| Q3 2025 | -25% | +48 points |
| Q2 2025 | -31% | +13 points |
| Q1 2025 | -28% | +119 points |
| Q4 2024 | -32% | +45 points |
CGC's operating margin was −28% last quarter, down 2.9 points from the same quarter a year ago.
CGC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.9M | +$2.6M |
| Q2 2026 | -$18.1M | -$9.9M |
| Q1 2026 | -$13.5M | +$11.9M |
| Q4 2025 | -$13.4M | +$6.4M |
| Q3 2025 | -$13.5M | +$26.2M |
| Q2 2025 | -$8.2M | +$31M |
| Q1 2025 | -$25.5M | -$9.8M |
| Q4 2024 | -$19.8M | +$3.5M |
CGC has burned cash in almost every quarter: −$56M over the past year, against −$67M the year before.
CGC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +846K shares |
| 1 year | +125% | +235M shares |
| 3 years | +770% | +374M shares |
| 5 years | +1035% | +386M shares |
CGC has 423M diluted shares, up 125% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CGC Net Leverage
CGC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CGC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.5 | Oversold |
| Stochastic | 6.6 | Oversold |
CGC's weekly RSI is 25 (oversold) and its Stochastic is 7 (oversold).
CGC PE vs Healthcare Sector
| Metric | CGC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CGC has no meaningful PE right now: it lost money over the past year.
CGC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.74 | 23% below |
| 20 week MA | $0.88 | 35% below |
| 50 week MA | $1.02 | 44% below |
| 100 week MA | $1.25 | 54% below |
| 200 week MA | $4.80 | 88% below |
CGC is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
CGC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $192.1 | $258.6 | +35% |
| 2021 | $258.6 | $96.2 | -63% |
| 2022 | $96.2 | $23.3 | -76% |
| 2023 | $23.3 | $5.11 | -78% |
| 2024 | $5.11 | $2.78 | -46% |
| 2025 | $2.78 | $1.19 | -57% |
| 2026 YTD | $1.19 | $0.57 | -52% |
CGC has finished five years in a row lower, and it's down 52% so far in 2026.